Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Vice President and Head of Quality at Dimension Therapeutics
Khandan Baradaran, Ph.D., is Vice President and Head of Quality at Dimension Therapeutics. Dr. Baradaran has extensive expertise in the areas of viral safety, gene therapy vector development, vaccine development and assay technologies. She has held positions of increasing responsibility in regulatory affairs, quality control and quality assurance, most recently as Vice President and Head of Regulatory Affairs and Quality Assurance at Dimension. Prior to joining Dimension Dr. Baradaran was responsible for early and late stage rare disease development programs utilizing novel medical device and gene therapy approaches at Shire Pharmaceuticals. Before joining Shire Dr. Baradaran was at Biogen, where she was Global Regulatory Lead for AVONEX®, an MS drug that is marketed in more than 100 countries. Prior to Biogen, Dr. Baradaran played significant roles in the submission and approval of KALBITOR® and FLUCELVAX®, as well as several clinical dossiers at Dyax Corp. and Novartis Vaccines and Diagnostics. Dr. Baradaran received her B.A. degree in molecular biology from Wellesley College and her Ph.D. in virology from Harvard University.